Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 2
2004 1
2005 1
2006 1
2007 3
2008 3
2009 1
2011 2
2012 1
2013 8
2014 5
2015 2
2016 2
2017 5
2018 6
2019 2
2020 4
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor.
Hallin J, Bowcut V, Calinisan A, Briere DM, Hargis L, Engstrom LD, Laguer J, Medwid J, Vanderpool D, Lifset E, Trinh D, Hoffman N, Wang X, David Lawson J, Gunn RJ, Smith CR, Thomas NC, Martinson M, Bergstrom A, Sullivan F, Bouhana K, Winski S, He L, Fernandez-Banet J, Pavlicek A, Haling JR, Rahbaek L, Marx MA, Olson P, Christensen JG. Hallin J, et al. Among authors: sullivan f. Nat Med. 2022 Oct;28(10):2171-2182. doi: 10.1038/s41591-022-02007-7. Epub 2022 Oct 10. Nat Med. 2022. PMID: 36216931
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer.
Fell JB, Fischer JP, Baer BR, Blake JF, Bouhana K, Briere DM, Brown KD, Burgess LE, Burns AC, Burkard MR, Chiang H, Chicarelli MJ, Cook AW, Gaudino JJ, Hallin J, Hanson L, Hartley DP, Hicken EJ, Hingorani GP, Hinklin RJ, Mejia MJ, Olson P, Otten JN, Rhodes SP, Rodriguez ME, Savechenkov P, Smith DJ, Sudhakar N, Sullivan FX, Tang TP, Vigers GP, Wollenberg L, Christensen JG, Marx MA. Fell JB, et al. Among authors: sullivan fx. J Med Chem. 2020 Jul 9;63(13):6679-6693. doi: 10.1021/acs.jmedchem.9b02052. Epub 2020 Apr 6. J Med Chem. 2020. PMID: 32250617 Free article.
Ocean Acidification and Human Health.
Falkenberg LJ, Bellerby RGJ, Connell SD, Fleming LE, Maycock B, Russell BD, Sullivan FJ, Dupont S. Falkenberg LJ, et al. Among authors: sullivan fj. Int J Environ Res Public Health. 2020 Jun 24;17(12):4563. doi: 10.3390/ijerph17124563. Int J Environ Res Public Health. 2020. PMID: 32599924 Free PMC article. Review.
Critical care transport.
Williams KA, Sullivan FM. Williams KA, et al. Among authors: sullivan fm. R I Med J (2013). 2013 Dec 3;96(12):39-43. R I Med J (2013). 2013. PMID: 24303517
Mesenchymal stem cells: key players in cancer progression.
Ridge SM, Sullivan FJ, Glynn SA. Ridge SM, et al. Among authors: sullivan fj. Mol Cancer. 2017 Feb 1;16(1):31. doi: 10.1186/s12943-017-0597-8. Mol Cancer. 2017. PMID: 28148268 Free PMC article. Review.
The yin and yang of nitric oxide in cancer progression.
Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. Burke AJ, et al. Among authors: sullivan fj. Carcinogenesis. 2013 Mar;34(3):503-12. doi: 10.1093/carcin/bgt034. Epub 2013 Jan 25. Carcinogenesis. 2013. PMID: 23354310 Review.
Development and progress of Ireland's biobank network: Ethical, legal, and social implications (ELSI), standardized documentation, sample and data release, and international perspective.
Mee B, Gaffney E, Glynn SA, Donatello S, Carroll P, Connolly E, Garrigle SM, Boyle T, Flannery D, Sullivan FJ, McCormick P, Griffin M, Muldoon C, Fay J, O'Grady T, Kay E, Eustace J, Burke L, Sheikh AA, Finn S, Flavin R, Giles FJ. Mee B, et al. Among authors: sullivan fj. Biopreserv Biobank. 2013 Feb;11(1):3-11. doi: 10.1089/bio.2012.0028. Biopreserv Biobank. 2013. PMID: 24845249 Free PMC article. Review.
50 results